Vise Technologies’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Buy |
+2,143
| New | +$1.12M | 0.05% | 407 |
|
|
2024
Q4 | $560K | Buy |
786
+323
| +70% | +$230K | 0.05% | 393 |
|
|
2024
Q3 | $487K | Buy |
463
+235
| +103% | +$247K | 0.06% | 308 |
|
|
2024
Q2 | $240K | Buy |
228
+16
| +8% | +$16.8K | 0.04% | 365 |
|
|
2024
Q1 | $204K | Buy |
+212
| New | +$204K | 0.04% | 361 |
|
|
2022
Q3 | – | Sell |
-412
| Closed | -$244K | – | 337 |
|
|
2022
Q2 | $244K | Buy |
+412
| New | +$244K | 0.09% | 243 |
|